The present results are at variance from data on DDX3 expression in FBC, where high nuclear DDX3 in the primary tumor was described as an independent predictor of worse survival [15, 16] and cytoplasmic DDX3 was not. The gene discussed is DDX3X; the disease is complete blood cell count.